Phase 3 Study to Evaluate Longterm Safety of Once-a-Day Dosing of Udenafil in the Treatment of Erectile Dysfunction

Trial Profile

Phase 3 Study to Evaluate Longterm Safety of Once-a-Day Dosing of Udenafil in the Treatment of Erectile Dysfunction

Completed
Phase of Trial: Phase III

Latest Information Update: 07 May 2017

At a glance

  • Drugs Udenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Adverse reactions; Registrational
  • Sponsors Dong-A Pharmaceutical
  • Most Recent Events

    • 27 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top